Transaction in Own Shares

Source: RNS
RNS Number : 8567U
Ingenta PLC
03 July 2024
 

3 July 2024

 

Ingenta plc

("Ingenta" or the "Company")

 

Transaction in own shares

 

The Company confirms that, pursuant to the authority granted at its 2023 Annual General Meeting, it has purchased, through Cavendish Capital Markets Limited, 25,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares") for cancellation at a price of 114p per share.

 

Date of purchase:

2 July 2024

Number of Ordinary Shares purchased (aggregated volume):

25,000

Highest price paid per Ordinary Share (pence):

114

Lowest price paid per Ordinary Share (pence):

114

Volume weighted average price paid per share Ordinary Share (pence):

114

Volume weighted average price paid per share Ordinary Share (pence):

114

 

Following the cancellation of the Ordinary Shares, the Company's issued share capital will consist of 15,098,125 Ordinary Shares, of which 587,930 continue to be held in Treasury. Accordingly, the Company will have total voting rights of 14,510,195 following cancellation. This figure (14,510,195) represents the total voting rights in the Company which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure Guidance and Transparency Rules of the FCA.

 

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, a detailed breakdown of individual trades is available below:

  

Number of shares purchased

Transaction price
(pence per share)

Time of transaction

Venue

25,000

114

13:30:10

AIMX

  

 

For further information contact:

 

Ingenta Plc
Scott Winner, Jon Sheffield

+44 (0) 1865 397 800

Cavendish Capital Markets Limited

Katy Birkin, Callum Davidson

+44 (0) 20 7397 8900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBUGDRCXGDGSD